Immune Therapeutics, Inc.
OTC: IMUN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Noreen M. Griffin
- Headquarters
- Winter Park, United States
- IPO year
- 2010
- Market cap
- $7.8M
- Website
- https://www.immunetherapeutics.com
Loading IMUN…
Loading profile data…Frequently asked questions about IMUN
What does Immune Therapeutics, Inc. (IMUN) do?
Immune Therapeutics, Inc. currently conducts no significant business operations. Formerly known as TNI BioTech, Inc., the company adopted its present name in October 2014. Its corporate headquarters are situated in Orlando, Florida.
Where does IMUN trade?
Immune Therapeutics, Inc. (IMUN) trades on the Other OTC.
What sector is IMUN in?
Immune Therapeutics, Inc. (IMUN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Immune Therapeutics, Inc.?
Noreen M. Griffin is the chief executive officer of Immune Therapeutics, Inc. (IMUN).
Where is Immune Therapeutics, Inc. headquartered?
Immune Therapeutics, Inc. is headquartered in United States.
Does IMUN pay a dividend?
Immune Therapeutics, Inc. (IMUN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IMUN go public?
Immune Therapeutics, Inc. (IMUN) completed its initial public offering in 2010.